VERU Veru Inc
Company Analysis
Latest News
🔴 Veru Inc is trading 5% down today with no clear catalyst yet
Veru Inc is trading 5% down at $2.84 today, underperforming a broadly positive market backdrop despite a lack of fresh company-specific headlines. • The...
🔴 Veru Inc is trading 5.3% down today as it gives back part of last week's gains
Veru Inc is trading 5.3% down today at $2.96 as the stock retreats following a sharp rebound last week. • The decline occurred on light liquidity with no...
🔴 Veru Inc is trading 6.2% down today with no clear catalyst amid light pre-market liquidity
Veru Inc is trading 6.2% down at $2.94 in pre-market sessions with no clear catalyst for the move. • The decline gives back a portion of the June 15 rebound...
🟢 Veru Inc is trading 5.2% up today, rebounding amid broad risk-on market sentiment
Veru Inc is trading 5.2% higher at $3.15, recovering a portion of last week’s steep pullback following a Novo Nordisk-driven rally. • The move appears tied to...
🔴 Veru Inc is trading 5.4% down today on profit-taking after its recent Novo Nordisk-driven rally
Veru Inc is trading at $3.08 (-5.37%) as the stock faces profit-taking following a sharp rally tied to its clinical supply agreement with Novo Nordisk. • The...
🟢 Veru Inc is trading 9% up today on its obesity-trial supply deal with Novo Nordisk
Veru Inc is trading at $3.21 (+8.98%) as shares continue to react to a clinical supply agreement with Novo Nordisk for the enobosarm obesity trial. * The...
🟢 Veru Inc. trading 11.5% higher, continuing volatile week after Novo Nordisk agreement
Veru Inc. is trading 11.5% up at $3.29, continuing a period of high volatility following a major company announcement earlier in the week. • On June 4, Veru...
🟢 Veru Inc is trading 10.34% up today as it rebounds from a two-day selloff following its Novo Nordisk deal surge
Veru Inc is trading at $3.31 (+10.34%) as it rebounds from a sharp two-day selloff following its June 4 surge tied to the Novo Nordisk supply agreement. • The...
🟢 Veru Inc is trading 5% up today as it rebounds from a sharp pullback following its Novo Nordisk deal surge
Veru Inc is trading at $3.15 (5% up) as it stages a technical rebound following sharp declines that followed its June 4 surge on a Novo Nordisk supply...
🔴 Veru Inc is trading 5.3% down today as it extends a pullback following its recent surge
Veru Inc is trading at $2.84 (-5.33%) in pre-market as the stock continues to pull back from its massive June 4 rally. • The decline follows a period of...
🔴 Veru Inc is trading 11.7% down today as it pulls back from its Novo Nordisk supply agreement surge
Veru Inc is trading 11.7% down at $3.00 as it continues to pull back from a massive surge triggered by its supply agreement with Novo Nordisk. • The stock is...
🔴 Veru Inc is trading 12.6% down today as it extends a pullback following its recent Novo Nordisk deal surge
Veru Inc is trading 12.6% down at $2.97 in pre-market, extending a pullback that followed a massive rally triggered by a clinical trial supply agreement with...
🔴 Veru Inc is trading 5.6% down today on continued profit-taking after Novo Nordisk deal surge
Veru Inc is trading 5.6% down at $3.21 in after-hours trading as investors continue to take profits following a massive rally triggered by its clinical trial...
🔴 Veru Inc is trading 11.8% down today after profit-taking following its Novo Nordisk deal rally
Veru Inc is trading at $3.73 (-11.82%) as the stock undergoes a sharp pullback following a significant rally in the previous session. • The recent surge was...
🔴 Veru Inc is trading 6.9% down today on profit-taking after its Novo Nordisk agreement surge
Veru Inc is trading at $3.94 (6.9% down) as the stock undergoes normalization and profit-taking following an 88% jump driven by its new clinical supply...
Veru Announces Clinical Supply Agreement with Novo Nordisk for Phase 2b Obesity Trial
Veru Inc. has entered into a clinical supply agreement with Novo Nordisk A/S to support its Phase 2b PLATEAU clinical study. The study will evaluate the...
Veru Landed a Novo Nordisk Deal and Doubled in a Day — But Can a $60 Million Biotech Sustain the Hype?
Shares of Veru Inc. (VERU) are pulling back 10.4% to $3.79 this morning after an explosive rally that saw the stock surge as much as 161% intraday on...
🔴 Veru Inc is trading 10.4% down today on profit-taking after yesterday's 88% surge from a Novo Nordisk deal
Veru Inc is trading 10.4% down at $3.79 as the stock undergoes consolidation and profit-taking following yesterday's massive 88% rally. • The prior-day surge...
Veru stock surges on Novo Nordisk deal for Wegovy obesity trial
Veru Inc. entered a clinical supply agreement with Novo Nordisk for the Phase 2b PLATEAU trial. Novo Nordisk will provide its weight-loss drug Wegovy...